Aurobindo Pharma approves ₹800 cr share buyback plan
pre-market1 source ↓written by the desknot a recommendation
- buyback
- ₹800 crore
- equity shares
- 54.23 lakh
- each
- ₹1,475
- over the previous
- 10% premium
- closing price
- ₹1,335.95
Aurobindo Pharma's Board has approved a ₹800 crore buyback of over 54.23 lakh equity shares at ₹1,475 each, representing a 10% premium over the previous closing price of ₹1,335.95. The buyback aims to enhance shareholder value and is set for April 17, 2026 as the record date for eligibility. This marks the company's second buyback in under two years.
Not investment advice. For informational purposes only.